Moreover, if lung cancer cells are more sensitive than healthy lung cells to the pro-apoptotic and pro-necrotic effects of TSPO ligands, such ligands may serve as potential candidates for the treatment of lung cancer. The gene discussed is TSPO; the disease is lung cancer.